General Anesthesia Drugs - Global and China Top Players Market Share and Ranking 2023
According to Latest Study, the global market for General Anesthesia Drugs should grow from US$ 3925.7 million in 2022 to US$ 4982.9 million by 2029, with a CAGR of 3.5% for the period of 2023-2029.
Global key players of general anesthesia drugs include Fresenius-Kabi, Baxter Healthcare, Aspen Pharma, etc. The top three players hold a share about 37%. Americas is the largest market, has a share about 36%, followed by Asia-Pacific and Europe, with share 29% and 28%, separately.
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
This report studies and analyses global General Anesthesia Drugs status and future trends, helps the client to determine the General Anesthesia Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for General Anesthesia Drugs, and provides market size (in M Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global General Anesthesia Drugs market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (M Units)
(2) Global General Anesthesia Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (M Units)
(3) China General Anesthesia Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (M Units)
(4) Global General Anesthesia Drugs key consuming regions, consumption quantity, consumption value and demand structure
(5) Global General Anesthesia Drugs key producing regions, capacity, production, and year over year growth
(6) General Anesthesia Drugs industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Market segment by Type, covers
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Others
Market segment by Application, can be divided into
Intravenous Anesthetics
Inhalational Anesthetics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe General Anesthesia Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global General Anesthesia Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China General Anesthesia Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of General Anesthesia Drugs, percent & CAGR, 2018-2029
Chapter 5: General Anesthesia Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 General Anesthesia Drugs Definition
1.2 Global General Anesthesia Drugs Market Size and Forecast
1.2.1 By Consumption Value, Global General Anesthesia Drugs Market Size，2018-2029
1.2.2 By Sales Quantity, Global General Anesthesia Drugs Market Size，2018-2029
1.2.3 Global General Anesthesia Drugs Average Selling Price (ASP)，2018-2029
1.3 China General Anesthesia Drugs Market Size and Forecast
1.3.1 By Consumption Value, China General Anesthesia Drugs Market Size，2018-2029
1.3.2 By Sales Quantity, China General Anesthesia Drugs Market Size，2018-2029
1.3.3 China General Anesthesia Drugs Average Selling Price (ASP)， 2018-2029
1.4 Share of China General Anesthesia Drugs Market with Respect to the Global Market
1.4.1 By Consumption Value, China General Anesthesia Drugs Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China General Anesthesia Drugs Market Share in Global, 2018-2029
1.4.3 General Anesthesia Drugs Market Size: China VS Global, 2018-2029
1.5 General Anesthesia Drugs Market Dynamics
1.5.1 General Anesthesia Drugs Market Drivers
1.5.2 General Anesthesia Drugs Market Restraints
1.5.3 General Anesthesia Drugs Industry Trends
1.5.4 General Anesthesia Drugs Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of General Anesthesia Drugs, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of General Anesthesia Drugs, Global Market Share by Company, 2018-2023
2.3 General Anesthesia Drugs Average Selling Price (ASP) by Company, 2018-2023
2.4 Global General Anesthesia Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global General Anesthesia Drugs Concentration Ratio
2.6 Global General Anesthesia Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global General Anesthesia Drugs Manufacturers Product Type
2.8 Head Office and General Anesthesia Drugs Production Site of Key Manufacturer
2.9 General Anesthesia Drugs Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of General Anesthesia Drugs, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of General Anesthesia Drugs, China Market Share by Company, 2018-2023
3.3 China General Anesthesia Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global General Anesthesia Drugs Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global General Anesthesia Drugs Capacity by Region
4.3 Global General Anesthesia Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global General Anesthesia Drugs Production by Region, 2018-2029
4.5 Global General Anesthesia Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 General Anesthesia Drugs Industry Chain
5.2 General Anesthesia Drugs Upstream Analysis
5.2.1 General Anesthesia Drugs Core Raw Materials
5.2.2 Main Manufacturers of General Anesthesia Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 General Anesthesia Drugs Production Mode
5.6 General Anesthesia Drugs Procurement Model
5.7 General Anesthesia Drugs Industry Sales Model and Sales Channels
5.7.1 General Anesthesia Drugs Sales Model
5.7.2 General Anesthesia Drugs Typical Distributors
6 Sights by Type
6.1 General Anesthesia Drugs Classification
6.1.1 Propofol
6.1.2 Sevoflurane
6.1.3 Remifentanil
6.1.4 Etomidate
6.1.5 Isoflurane
6.1.6 Others
6.2 By Type, Global General Anesthesia Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global General Anesthesia Drugs Consumption Value, 2018-2029
6.4 By Type, Global General Anesthesia Drugs Sales Quantity, 2018-2029
6.5 By Type, Global General Anesthesia Drugs Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 General Anesthesia Drugs Segment by Application
7.1.1 Intravenous Anesthetics
7.1.2 Inhalational Anesthetics
7.2 By Application, Global General Anesthesia Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global General Anesthesia Drugs Consumption Value, 2018-2029
7.4 By Application, Global General Anesthesia Drugs Sales Quantity, 2018-2029
7.5 By Application, Global General Anesthesia Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global General Anesthesia Drugs Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global General Anesthesia Drugs Consumption Value, 2018-2029
8.3 By Region, Global General Anesthesia Drugs Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America General Anesthesia Drugs & Forecasts, 2018-2029
8.4.2 By Country, North America General Anesthesia Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe General Anesthesia Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe General Anesthesia Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific General Anesthesia Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific General Anesthesia Drugs Market Size Market Share
8.7 South America
8.7.1 South America General Anesthesia Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America General Anesthesia Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global General Anesthesia Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global General Anesthesia Drugs Consumption Value, 2018-2029
9.3 By Country, Global General Anesthesia Drugs Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. General Anesthesia Drugs Market Size, 2018-2029
9.4.2 By Type, U.S. General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe General Anesthesia Drugs Market Size, 2018-2029
9.5.2 By Type, Europe General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China General Anesthesia Drugs Market Size, 2018-2029
9.6.2 By Type, China General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan General Anesthesia Drugs Market Size, 2018-2029
9.7.2 By Type, Japan General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea General Anesthesia Drugs Market Size, 2018-2029
9.8.2 By Type, South Korea General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia General Anesthesia Drugs Market Size, 2018-2029
9.9.2 By Type, Southeast Asia General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India General Anesthesia Drugs Market Size, 2018-2029
9.10.2 By Type, India General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa General Anesthesia Drugs Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Aspen Pharma
10.1.1 Aspen Pharma Company Information, Head Office, Market Area, and Industry Position
10.1.2 Aspen Pharma General Anesthesia Drugs Models, Specifications, and Application
10.1.3 Aspen Pharma General Anesthesia Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Aspen Pharma Company Profile and Main Business
10.1.5 Aspen Pharma Recent Developments
10.2 Fresenius-Kabi
10.2.1 Fresenius-Kabi Company Information, Head Office, Market Area, and Industry Position
10.2.2 Fresenius-Kabi General Anesthesia Drugs Models, Specifications, and Application
10.2.3 Fresenius-Kabi General Anesthesia Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Fresenius-Kabi Company Profile and Main Business
10.2.5 Fresenius-Kabi Recent Developments
10.3 AbbVie
10.3.1 AbbVie Company Information, Head Office, Market Area, and Industry Position
10.3.2 AbbVie General Anesthesia Drugs Models, Specifications, and Application
10.3.3 AbbVie General Anesthesia Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 AbbVie Company Profile and Main Business
10.3.5 AbbVie Recent Developments
10.4 Baxter Healthcare
10.4.1 Baxter Healthcare Company Information, Head Office, Market Area, and Industry Position
10.4.2 Baxter Healthcare General Anesthesia Drugs Models, Specifications, and Application
10.4.3 Baxter Healthcare General Anesthesia Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Baxter Healthcare Company Profile and Main Business
10.4.5 Baxter Healthcare Recent Developments
10.5 B.Braun
10.5.1 B.Braun Company Information, Head Office, Market Area, and Industry Position
10.5.2 B.Braun General Anesthesia Drugs Models, Specifications, and Application
10.5.3 B.Braun General Anesthesia Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 B.Braun Company Profile and Main Business
10.5.5 B.Braun Recent Developments
10.6 Maruishi
10.6.1 Maruishi Company Information, Head Office, Market Area, and Industry Position
10.6.2 Maruishi General Anesthesia Drugs Models, Specifications, and Application
10.6.3 Maruishi General Anesthesia Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Maruishi Company Profile and Main Business
10.6.5 Maruishi Recent Developments
10.7 Piramal
10.7.1 Piramal Company Information, Head Office, Market Area, and Industry Position
10.7.2 Piramal General Anesthesia Drugs Models, Specifications, and Application
10.7.3 Piramal General Anesthesia Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Piramal Company Profile and Main Business
10.7.5 Piramal Recent Developments
10.8 Hikma Pharmaceuticals
10.8.1 Hikma Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.8.2 Hikma Pharmaceuticals General Anesthesia Drugs Models, Specifications, and Application
10.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Hikma Pharmaceuticals Company Profile and Main Business
10.8.5 Hikma Pharmaceuticals Recent Developments
10.9 Yichang Humanwell
10.9.1 Yichang Humanwell Company Information, Head Office, Market Area, and Industry Position
10.9.2 Yichang Humanwell General Anesthesia Drugs Models, Specifications, and Application
10.9.3 Yichang Humanwell General Anesthesia Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Yichang Humanwell Company Profile and Main Business
10.9.5 Yichang Humanwell Recent Developments
10.10 Nhwa
10.10.1 Nhwa Company Information, Head Office, Market Area, and Industry Position
10.10.2 Nhwa General Anesthesia Drugs Models, Specifications, and Application
10.10.3 Nhwa General Anesthesia Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Nhwa Company Profile and Main Business
10.10.5 Nhwa Recent Developments
10.11 Hengrui
10.11.1 Hengrui Company Information, Head Office, Market Area, and Industry Position
10.11.2 Hengrui General Anesthesia Drugs Models, Specifications, and Application
10.11.3 Hengrui General Anesthesia Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Hengrui Company Profile and Main Business
10.11.5 Hengrui Recent Developments
10.12 Xi'an Libang
10.12.1 Xi'an Libang Company Information, Head Office, Market Area, and Industry Position
10.12.2 Xi'an Libang General Anesthesia Drugs Models, Specifications, and Application
10.12.3 Xi'an Libang General Anesthesia Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Xi'an Libang Company Profile and Main Business
10.12.5 Xi'an Libang Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. General Anesthesia Drugs Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. General Anesthesia Drugs Market Restraints
Table 3. General Anesthesia Drugs Market Trends
Table 4. General Anesthesia Drugs Industry Policy
Table 5. Global General Anesthesia Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global General Anesthesia Drugs Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global General Anesthesia Drugs Sales Quantity by Company, (2018-2023) & (M Units), Ranked Based on Sales in 2022
Table 8. Global General Anesthesia Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global General Anesthesia Drugs Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global General Anesthesia Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global General Anesthesia Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global General Anesthesia Drugs Manufacturers Product Type
Table 13. Head Office and General Anesthesia Drugs Production Site of Key Manufacturer
Table 14. General Anesthesia Drugs Capacity of Major Manufacturers and Future Plan
Table 15. China General Anesthesia Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China General Anesthesia Drugs Sales Quantity by Company, (2018-2023) & (M Units), Ranked Based on Sales in 2022
Table 17. China General Anesthesia Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global General Anesthesia Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (M Units)
Table 19. Global General Anesthesia Drugs Production by Region, 2018-2023, (M Units)
Table 20. Global General Anesthesia Drugs Production Forecast by Region, 2024-2029, (M Units)
Table 21. Global Key Players of General Anesthesia Drugs Upstream (Raw Materials)
Table 22. Global General Anesthesia Drugs Typical Customers
Table 23. General Anesthesia Drugs Typical Distributors
Table 24. By Type, Global General Anesthesia Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global General Anesthesia Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global General Anesthesia Drugs Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global General Anesthesia Drugs Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global General Anesthesia Drugs Sales Quantity, 2018-2029, (M Units)
Table 29. By Country, Global General Anesthesia Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global General Anesthesia Drugs Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global General Anesthesia Drugs Consumption Value Market Share, 2018-2029
Table 32. By Country, Global General Anesthesia Drugs Sales Quantity, 2018-2029, (M Units)
Table 33. By Country, Global General Anesthesia Drugs Sales Quantity Market Share, 2018-2029
Table 34. Aspen Pharma Company Information, Head Office, Market Area, and Industry Position
Table 35. Aspen Pharma General Anesthesia Drugs Models, Specifications, and Application
Table 36. Aspen Pharma General Anesthesia Drugs Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Aspen Pharma Company Profile and Main Business
Table 38. Aspen Pharma Recent Developments
Table 39. Fresenius-Kabi Company Information, Head Office, Market Area, and Industry Position
Table 40. Fresenius-Kabi General Anesthesia Drugs Models, Specifications, and Application
Table 41. Fresenius-Kabi General Anesthesia Drugs Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Fresenius-Kabi Company Profile and Main Business
Table 43. Fresenius-Kabi Recent Developments
Table 44. AbbVie Company Information, Head Office, Market Area, and Industry Position
Table 45. AbbVie General Anesthesia Drugs Models, Specifications, and Application
Table 46. AbbVie General Anesthesia Drugs Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. AbbVie Company Profile and Main Business
Table 48. AbbVie Recent Developments
Table 49. Baxter Healthcare Company Information, Head Office, Market Area, and Industry Position
Table 50. Baxter Healthcare General Anesthesia Drugs Models, Specifications, and Application
Table 51. Baxter Healthcare General Anesthesia Drugs Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Baxter Healthcare Company Profile and Main Business
Table 53. Baxter Healthcare Recent Developments
Table 54. B.Braun Company Information, Head Office, Market Area, and Industry Position
Table 55. B.Braun General Anesthesia Drugs Models, Specifications, and Application
Table 56. B.Braun General Anesthesia Drugs Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. B.Braun Company Profile and Main Business
Table 58. B.Braun Recent Developments
Table 59. Maruishi Company Information, Head Office, Market Area, and Industry Position
Table 60. Maruishi General Anesthesia Drugs Models, Specifications, and Application
Table 61. Maruishi General Anesthesia Drugs Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Maruishi Company Profile and Main Business
Table 63. Maruishi Recent Developments
Table 64. Piramal Company Information, Head Office, Market Area, and Industry Position
Table 65. Piramal General Anesthesia Drugs Models, Specifications, and Application
Table 66. Piramal General Anesthesia Drugs Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Piramal Company Profile and Main Business
Table 68. Piramal Recent Developments
Table 69. Hikma Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 70. Hikma Pharmaceuticals General Anesthesia Drugs Models, Specifications, and Application
Table 71. Hikma Pharmaceuticals General Anesthesia Drugs Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Hikma Pharmaceuticals Company Profile and Main Business
Table 73. Hikma Pharmaceuticals Recent Developments
Table 74. Yichang Humanwell Company Information, Head Office, Market Area, and Industry Position
Table 75. Yichang Humanwell General Anesthesia Drugs Models, Specifications, and Application
Table 76. Yichang Humanwell General Anesthesia Drugs Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Yichang Humanwell Company Profile and Main Business
Table 78. Yichang Humanwell Recent Developments
Table 79. Nhwa Company Information, Head Office, Market Area, and Industry Position
Table 80. Nhwa General Anesthesia Drugs Models, Specifications, and Application
Table 81. Nhwa General Anesthesia Drugs Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Nhwa Company Profile and Main Business
Table 83. Nhwa Recent Developments
Table 84. Hengrui Company Information, Head Office, Market Area, and Industry Position
Table 85. Hengrui General Anesthesia Drugs Models, Specifications, and Application
Table 86. Hengrui General Anesthesia Drugs Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Hengrui Company Profile and Main Business
Table 88. Hengrui Recent Developments
Table 89. Xi'an Libang Company Information, Head Office, Market Area, and Industry Position
Table 90. Xi'an Libang General Anesthesia Drugs Models, Specifications, and Application
Table 91. Xi'an Libang General Anesthesia Drugs Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Xi'an Libang Company Profile and Main Business
Table 93. Xi'an Libang Recent Developments
List of Figures
Figure 1. General Anesthesia Drugs Picture
Figure 2. Global General Anesthesia Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global General Anesthesia Drugs Sales Quantity, (M Units) & (2018-2029)
Figure 4. Global General Anesthesia Drugs Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China General Anesthesia Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 6. China General Anesthesia Drugs Sales Quantity (M Units) & (2018-2029)
Figure 7. China General Anesthesia Drugs Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China General Anesthesia Drugs Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China General Anesthesia Drugs Market Share of Global, 2018-2029
Figure 10. Global General Anesthesia Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China General Anesthesia Drugs Key Participants, Market Share, 2022
Figure 12. Global General Anesthesia Drugs Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global General Anesthesia Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global General Anesthesia Drugs Production Market Share & Forecast by Region, 2018-2029
Figure 15. General Anesthesia Drugs Industry Chain
Figure 16. General Anesthesia Drugs Procurement Model
Figure 17. General Anesthesia Drugs Sales Model
Figure 18. General Anesthesia Drugs Sales Channels, Direct Sales, and Distribution
Figure 19. Propofol
Figure 20. Sevoflurane
Figure 21. Remifentanil
Figure 22. Etomidate
Figure 23. Isoflurane
Figure 24. Others
Figure 25. By Type, Global General Anesthesia Drugs Consumption Value, 2018-2029, US$ Million
Figure 26. By Type, Global General Anesthesia Drugs Consumption Value Market Share, 2018-2029
Figure 27. By Type, Global General Anesthesia Drugs Sales Quantity, 2018-2029, (M Units)
Figure 28. By Type, Global General Anesthesia Drugs Sales Quantity Market Share, 2018-2029
Figure 29. By Type, Global General Anesthesia Drugs Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 30. Intravenous Anesthetics
Figure 31. Inhalational Anesthetics
Figure 32. By Application, Global General Anesthesia Drugs Consumption Value, 2018-2029, US$ Million
Figure 33. By Application, Global General Anesthesia Drugs Consumption Value Market Share, 2018-2029
Figure 34. By Application, Global General Anesthesia Drugs Sales Quantity, 2018-2029, (M Units)
Figure 35. By Application, Global General Anesthesia Drugs Sales Quantity Market Share, 2018-2029
Figure 36. By Application, Global General Anesthesia Drugs Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 37. By Region, Global General Anesthesia Drugs Consumption Value Market Share, 2018-2029
Figure 38. By Region, Global General Anesthesia Drugs Sales Quantity Market Share, 2018-2029
Figure 39. North America General Anesthesia Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America General Anesthesia Drugs Consumption Value Market Share, 2022
Figure 41. Europe General Anesthesia Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe General Anesthesia Drugs Consumption Value Market Share, 2022
Figure 43. Asia Pacific General Anesthesia Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific General Anesthesia Drugs Consumption Value Market Share, 2022
Figure 45. South America General Anesthesia Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America General Anesthesia Drugs Consumption Value Market Share, 2022
Figure 47. Middle East & Africa General Anesthesia Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. General Anesthesia Drugs Sales Quantity, 2018-2029, (M Units)
Figure 49. By Type, U.S. General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, U.S. General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 51. Europe General Anesthesia Drugs Sales Quantity, 2018-2029, (M Units)
Figure 52. By Type, Europe General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, Europe General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 54. China General Anesthesia Drugs Sales Quantity, 2018-2029, (M Units)
Figure 55. By Type, China General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, China General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 57. Japan General Anesthesia Drugs Sales Quantity, 2018-2029, (M Units)
Figure 58. By Type, Japan General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, Japan General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 60. South Korea General Anesthesia Drugs Sales Quantity, 2018-2029, (M Units)
Figure 61. By Type, South Korea General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, South Korea General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 63. Southeast Asia General Anesthesia Drugs Sales Quantity, 2018-2029, (M Units)
Figure 64. By Type, Southeast Asia General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, Southeast Asia General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 66. India General Anesthesia Drugs Sales Quantity, 2018-2029, (M Units)
Figure 67. By Type, India General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, India General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 69. Middle East & Africa General Anesthesia Drugs Sales Quantity, 2018-2029, (M Units)
Figure 70. By Type, Middle East & Africa General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 71. By Application, Middle East & Africa General Anesthesia Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 72. Research Methodology
Figure 73. Breakdown of Primary Interviews
Figure 74. Bottom-up and Top-down Approaches
Figure 75. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|